Tag: Merck

Merck to acquire Imago BioSciences to expand blood disorder drugs portfolio

Raghuram Kadari- November 23, 2022

Pharma giant Merck will acquire Imago BioSciences, a Nasdaq-listed clinical stage biopharmaceutical company, for a price of $36 per share in cash, which translates to ... Read More

Cue Biopharma gets FDA fast track status for CUE-101 in HPV16+ R/M HNSCC

businessnewstoday- October 5, 2022

Cue Biopharma has been granted fast track designation for CUE-101 from the US Food and Drug Administration (FDA) for the treatment of a type of ... Read More

Zydus Lifesciences gets tentative FDA approval for Sugammadex generic

- September 18, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for Sugammadex Injection USP 200 mg/2 mL (100 ... Read More

Merck signs $290m deal with Orion Corporation for mCRPC candidate ODM-208

- July 16, 2022

Merck has signed a global development and commercialization deal worth $290 million with Orion Corporation for the latter’s investigational candidate ODM-208 and other drugs that ... Read More

PDS Biotechnology gets FDA fast track status for PDS0101

- June 5, 2022

PDS Biotechnology has secured fast track designation to its PDS0101 in combination with Merck’s KEYTRUDA (pembrolizumab) from the US Food and Drug Administration (FDA) for ... Read More

Merck to invest €440m in Ireland to expand membrane and filtration manufacturing

- May 24, 2022

Merck will expand its membrane and filtration manufacturing capabilities in Ireland with an investment of around €440 million. The pharma giant will use the investment ... Read More

Merck to acquire US biopharma CDMO Exelead for $780m

- January 7, 2022

Pharma giant Merck has signed an all-cash deal worth around $780 million to acquire Exelead, an Indiana-based biopharmaceutical contract development and manufacturing organization (biopharma CDMO). ... Read More

Aurobindo Pharma gets DCGI nod for Molnupiravir generic version

- December 29, 2021

Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More

Zydus Cadila gets FDA tentative approval for Sitagliptin base tablets

- September 6, 2021

Zydus Cadila said that its subsidiary has been granted tentative approval from the US Food and Drug Administration (FDA) for its new drug application (NDA) ... Read More

Unichem Laboratories gets FDA approval for Sitagliptin Tablets

- July 10, 2021

Unichem Laboratories Limited said that it has secured tentative approval for abbreviated new drug application (ANDA) of Sitagliptin Tablets USP, 25 mg, 50 mg, and ... Read More